1. Home
  2. FOLD vs IRDM Comparison

FOLD vs IRDM Comparison

Compare FOLD & IRDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • IRDM
  • Stock Information
  • Founded
  • FOLD 2002
  • IRDM 2000
  • Country
  • FOLD United States
  • IRDM United States
  • Employees
  • FOLD N/A
  • IRDM N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • IRDM Telecommunications Equipment
  • Sector
  • FOLD Health Care
  • IRDM Telecommunications
  • Exchange
  • FOLD Nasdaq
  • IRDM Nasdaq
  • Market Cap
  • FOLD 2.8B
  • IRDM 3.4B
  • IPO Year
  • FOLD 2007
  • IRDM N/A
  • Fundamental
  • Price
  • FOLD $9.50
  • IRDM $28.47
  • Analyst Decision
  • FOLD Strong Buy
  • IRDM Buy
  • Analyst Count
  • FOLD 8
  • IRDM 4
  • Target Price
  • FOLD $17.57
  • IRDM $41.00
  • AVG Volume (30 Days)
  • FOLD 2.4M
  • IRDM 1.0M
  • Earning Date
  • FOLD 11-06-2024
  • IRDM 10-17-2024
  • Dividend Yield
  • FOLD N/A
  • IRDM 1.97%
  • EPS Growth
  • FOLD N/A
  • IRDM N/A
  • EPS
  • FOLD N/A
  • IRDM 0.93
  • Revenue
  • FOLD $493,671,000.00
  • IRDM $812,431,000.00
  • Revenue This Year
  • FOLD $33.97
  • IRDM $6.18
  • Revenue Next Year
  • FOLD $21.74
  • IRDM $3.78
  • P/E Ratio
  • FOLD N/A
  • IRDM $30.76
  • Revenue Growth
  • FOLD 32.58
  • IRDM 2.86
  • 52 Week Low
  • FOLD $9.02
  • IRDM $24.14
  • 52 Week High
  • FOLD $14.57
  • IRDM $41.66
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 28.33
  • IRDM 46.14
  • Support Level
  • FOLD $9.37
  • IRDM $27.15
  • Resistance Level
  • FOLD $9.68
  • IRDM $29.93
  • Average True Range (ATR)
  • FOLD 0.49
  • IRDM 1.08
  • MACD
  • FOLD -0.18
  • IRDM -0.19
  • Stochastic Oscillator
  • FOLD 3.96
  • IRDM 36.97

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About IRDM Iridium Communications Inc

Iridium Communications Inc offers voice and data communications services and products to businesses, U.S. and international government agencies, and other customers on a global basis. The company is a provider of mobile voice and data communications services through a constellation of low earth-orbiting satellites. Iridium's solutions are ideally suited for industries such as maritime, aviation, government/military, emergency/humanitarian services, mining, forestry, oil and gas, heavy equipment, transportation, and utilities. Iridium also provides service to subscribers from the U.S. Department of Defense, as well as other civil and government agencies around the world. The Company operates in one business segment, providing global satellite communications services and products.

Share on Social Networks: